Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Conservation conflict: Managing forestry versus hen harrier species under Europe's Birds Directive.

Bonsu NO, McMahon BJ, Meijer S, Young JC, Keane A, Dhubháin ÁN.

J Environ Manage. 2019 Dec 15;252:109676. doi: 10.1016/j.jenvman.2019.109676. Epub 2019 Oct 12.

PMID:
31614263
2.

Cascade of Care for Alaska Native People with Chronic Hepatitis C Virus Infection: Statewide Program with High Linkage to Care.

McMahon BJ, Townshend-Bulson L, Homan C, Gounder P, Barbour Y, Hewitt A, Bruden D, Espera H, Plotnik J, Gove J, Stevenson TJ, Luna SV, Simons BC.

Clin Infect Dis. 2019 Aug 28. pii: ciz832. doi: 10.1093/cid/ciz832. [Epub ahead of print]

PMID:
31504307
3.

Observed Changes in Natural Killer and T cell Phenotypes with Evaluation of Immune Outcome in a Longitudinal Cohort Following Sofosbuvir-Based Therapy for Chronic Hepatitis C Infection.

Stevenson TJ, Barbour Y, McMahon BJ, Townshend-Bulson L, Hewitt AM, Espera HGF, Homan C, Holck P, Luna SV, Knall C, Simons BC.

Open Forum Infect Dis. 2019 May 17;6(6):ofz223. doi: 10.1093/ofid/ofz223. eCollection 2019 Jun.

4.

Surveillance of Mosquitoes (Diptera, Culicidae) in a Northern Central Region of Spain: Implications for the Medical Community.

Ruiz-Arrondo I, McMahon BJ, Hernández-Triana LM, Santibañez P, Portillo A, Oteo JA.

Front Vet Sci. 2019 Apr 23;6:86. doi: 10.3389/fvets.2019.00086. eCollection 2019.

5.

Hepatitis C in pregnant American Indian and Alaska native women; 2003-2015.

Nolen LD, O'Malley JC, Seeman SS, Bruden DJT, Apostolou A, McMahon BJ, Bruce MG.

Int J Circumpolar Health. 2019 Dec;78(1):1608139. doi: 10.1080/22423982.2019.1608139.

6.

Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB.

Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-34. doi: 10.1002/cld.728. eCollection 2018 Jul. Review. No abstract available.

7.

Meeting the WHO and US Goals to Eliminate Hepatitis B Infection by 2030: Opportunities and Challenges.

McMahon BJ.

Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):29-32. doi: 10.1002/cld.733. eCollection 2018 Jul. Review. No abstract available.

8.

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.

Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou J, Howell J, Jia J, Kravchenko N, Lazarus JV, Lemoine M, Lesi OA, Maistat L, McMahon BJ, Razavi H, Roberts T, Simmons B, Sonderup MW, Spearman CW, Taylor BE, Thomas DL, Waked I, Ward JW, Wiktor SZ; Lancet Gastroenterology & Hepatology Commissioners.

Lancet Gastroenterol Hepatol. 2019 Feb;4(2):135-184. doi: 10.1016/S2468-1253(18)30270-X. Review. Erratum in: Lancet Gastroenterol Hepatol. 2019 May;4(5):e4.

9.

Summary of available surveillance data on hepatitis C virus infection from eight Arctic countries, 2012 to 2014.

Gounder PP, Koch A, Provo G, Lovlie A, Ederth JL, Axelsson M, Archibald CP, Hanley B, Mullen A, Matheson M, Allison D, Trykker H, Hennessy TW, Kuusi M, Chulanov V, McMahon BJ.

Euro Surveill. 2018 Oct;23(40). doi: 10.2807/1560-7917.ES.2018.23.40.1700408.

10.

H. pylori-associated pathologic findings among Alaska native patients.

Nolen LD, Bruden D, Miernyk K, McMahon BJ, Sacco F, Varner W, Mezzetti T, Hurlburt D, Tiesinga J, Bruce MG.

Int J Circumpolar Health. 2018 Dec;77(1):1510715. doi: 10.1080/22423982.2018.1510715.

11.

Ecosystem change and zoonoses in the Anthropocene.

McMahon BJ, Morand S, Gray JS.

Zoonoses Public Health. 2018 Nov;65(7):755-765. doi: 10.1111/zph.12489. Epub 2018 Aug 13. Review.

PMID:
30105852
12.

A scoping review on the prevalence of Shiga-toxigenic Escherichia coli in wild animal species.

Espinosa L, Gray A, Duffy G, Fanning S, McMahon BJ.

Zoonoses Public Health. 2018 Dec;65(8):911-920. doi: 10.1111/zph.12508. Epub 2018 Aug 11. Review.

PMID:
30099841
13.

Reply.

Terrault NA, Brown RS Jr, Lok AS, Wong JB, Bzowej NH, Chang KM, Hwang JP, Jonas MM, McMahon BJ.

Hepatology. 2018 Oct;68(4):1658-1660. doi: 10.1002/hep.30137. No abstract available.

14.

Antimicrobial Resistance in Listeria Species.

Luque-Sastre L, Arroyo C, Fox EM, McMahon BJ, Bai L, Li F, Fanning S.

Microbiol Spectr. 2018 Jul;6(4). doi: 10.1128/microbiolspec.ARBA-0031-2017. Review.

PMID:
30027884
15.

Predicting treatment eligibility for hepatitis B in low income regions: Can treatment scores without HBV DNA testing serve the purpose?

McMahon BJ, Dusheiko G.

J Hepatol. 2018 Oct;69(4):765-766. doi: 10.1016/j.jhep.2018.06.002. Epub 2018 Jul 11. No abstract available.

PMID:
30007507
16.

Hepatitis B Vaccination, Screening, and Linkage to Care.

Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM.

Ann Intern Med. 2018 Jun 19;168(12):902-903. doi: 10.7326/L18-0101. No abstract available.

PMID:
29913503
17.

An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People.

Hayashi S, Khan A, Simons BC, Homan C, Matsui T, Ogawa K, Kawashima K, Murakami S, Takahashi S, Isogawa M, Ikeo K, Mizokami M, McMahon BJ, Tanaka Y.

Hepatology. 2019 Jan;69(1):19-33. doi: 10.1002/hep.30111. Epub 2018 Dec 10.

PMID:
29893492
18.

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.

Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C, Alsharif U, Alvis-Guzman N, Amini E, Anderson BO, Aremu O, Artaman A, Asgedom SW, Assadi R, Atey TM, Avila-Burgos L, Awasthi A, Ba Saleem HO, Barac A, Bennett JR, Bensenor IM, Bhakta N, Brenner H, Cahuana-Hurtado L, Castañeda-Orjuela CA, Catalá-López F, Choi JJ, Christopher DJ, Chung SC, Curado MP, Dandona L, Dandona R, das Neves J, Dey S, Dharmaratne SD, Doku DT, Driscoll TR, Dubey M, Ebrahimi H, Edessa D, El-Khatib Z, Endries AY, Fischer F, Force LM, Foreman KJ, Gebrehiwot SW, Gopalani SV, Grosso G, Gupta R, Gyawali B, Hamadeh RR, Hamidi S, Harvey J, Hassen HY, Hay RJ, Hay SI, Heibati B, Hiluf MK, Horita N, Hosgood HD, Ilesanmi OS, Innos K, Islami F, Jakovljevic MB, Johnson SC, Jonas JB, Kasaeian A, Kassa TD, Khader YS, Khan EA, Khan G, Khang YH, Khosravi MH, Khubchandani J, Kopec JA, Kumar GA, Kutz M, Lad DP, Lafranconi A, Lan Q, Legesse Y, Leigh J, Linn S, Lunevicius R, Majeed A, Malekzadeh R, Malta DC, Mantovani LG, McMahon BJ, Meier T, Melaku YA, Melku M, Memiah P, Mendoza W, Meretoja TJ, Mezgebe HB, Miller TR, Mohammed S, Mokdad AH, Moosazadeh M, Moraga P, Mousavi SM, Nangia V, Nguyen CT, Nong VM, Ogbo FA, Olagunju AT, Pa M, Park EK, Patel T, Pereira DM, Pishgar F, Postma MJ, Pourmalek F, Qorbani M, Rafay A, Rawaf S, Rawaf DL, Roshandel G, Safiri S, Salimzadeh H, Sanabria JR, Santric Milicevic MM, Sartorius B, Satpathy M, Sepanlou SG, Shackelford KA, Shaikh MA, Sharif-Alhoseini M, She J, Shin MJ, Shiue I, Shrime MG, Sinke AH, Sisay M, Sligar A, Sufiyan MB, Sykes BL, Tabarés-Seisdedos R, Tessema GA, Topor-Madry R, Tran TT, Tran BX, Ukwaja KN, Vlassov VV, Vollset SE, Weiderpass E, Williams HC, Yimer NB, Yonemoto N, Younis MZ, Murray CJL, Naghavi M.

JAMA Oncol. 2018 Nov 1;4(11):1553-1568. doi: 10.1001/jamaoncol.2018.2706.

19.

Expectations for a new WHO Director General: health in a rapidly changing environment.

Rüegg SR, Machalaba C, McMahon BJ, Häsler B, Errecaborde KM, Pelican K, Kock R.

Lancet Planet Health. 2017 May;1(2):e44-e45. doi: 10.1016/S2542-5196(17)30022-0. Epub 2017 May 5. No abstract available.

20.

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB.

Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800. No abstract available.

21.

Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.

Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM; High Value Care Task Force of the American College of Physicians and the Centers for Disease Control and Prevention.

Ann Intern Med. 2017 Dec 5;167(11):794-804. doi: 10.7326/M17-1106. Epub 2017 Nov 21.

PMID:
29159414
22.

Multi-criteria Decision Analysis to Model Ixodes ricinus Habitat Suitability.

Rousseau R, McGrath G, McMahon BJ, Vanwambeke SO.

Ecohealth. 2017 Sep;14(3):591-602. doi: 10.1007/s10393-017-1247-8. Epub 2017 Jun 19.

PMID:
28631117
23.

Prevalence and correlates of hepatitis C virus-associated inflammatory arthritis in a population-based cohort.

Ferucci ED, Choromanski TL, Varney DT, Ryan HS, Townshend-Bulson LJ, McMahon BJ, Wener MH.

Semin Arthritis Rheum. 2017 Dec;47(3):445-450. doi: 10.1016/j.semarthrit.2017.04.004. Epub 2017 Apr 24.

PMID:
28532574
24.

Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance - authors' reply.

Gounder PP, Mosites EM, McMahon BJ.

Aliment Pharmacol Ther. 2017 May;45(9):1288-1289. doi: 10.1111/apt.14026. No abstract available.

25.

Don't forget to look down - collaborative approaches to predator conservation.

Redpath SM, Linnell JDC, Festa-Bianchet M, Boitani L, Bunnefeld N, Dickman A, Gutiérrez RJ, Irvine RJ, Johansson M, Majić A, McMahon BJ, Pooley S, Sandström C, Sjölander-Lindqvist A, Skogen K, Swenson JE, Trouwborst A, Young J, Milner-Gulland EJ.

Biol Rev Camb Philos Soc. 2017 Nov;92(4):2157-2163. doi: 10.1111/brv.12326. Epub 2017 Mar 24. Review.

PMID:
28338282
26.

A Blueprint to Evaluate One Health.

Rüegg SR, McMahon BJ, Häsler B, Esposito R, Nielsen LR, Ifejika Speranza C, Ehlinger T, Peyre M, Aragrande M, Zinsstag J, Davies P, Mihalca AD, Buttigieg SC, Rushton J, Carmo LP, De Meneghi D, Canali M, Filippitzi ME, Goutard FL, Ilieski V, Milićević D, O'Shea H, Radeski M, Kock R, Staines A, Lindberg A.

Front Public Health. 2017 Feb 16;5:20. doi: 10.3389/fpubh.2017.00020. eCollection 2017.

27.

Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics.

Block TM, Locarnini S, McMahon BJ, Rehermann B, Peters MG.

Clin Infect Dis. 2017 May 1;64(9):1283-1288. doi: 10.1093/cid/cix129. Review.

28.

Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.

Bruden DJT, McMahon BJ, Townshend-Bulson L, Gounder P, Gove J, Plotnik J, Homan C, Hewitt A, Barbour Y, Spradling PR, Simons BC, McArdle S, Bruce M.

Hepatology. 2017 Jul;66(1):37-45. doi: 10.1002/hep.29115. Epub 2017 May 22.

29.

Persistence of antibody to Hepatitis A virus 20 years after receipt of Hepatitis A vaccine in Alaska.

Plumb ID, Bulkow LR, Bruce MG, Hennessy TW, Morris J, Rudolph K, Spradling P, Snowball M, McMahon BJ.

J Viral Hepat. 2017 Jul;24(7):608-612. doi: 10.1111/jvh.12676. Epub 2017 Feb 2.

PMID:
28092416
30.

Emerging Infectious Disease Implications of Invasive Mammalian Species: The Greater White-Toothed Shrew (Crocidura russula) Is Associated With a Novel Serovar of Pathogenic Leptospira in Ireland.

Nally JE, Arent Z, Bayles DO, Hornsby RL, Gilmore C, Regan S, McDevitt AD, Yearsley J, Fanning S, McMahon BJ.

PLoS Negl Trop Dis. 2016 Dec 9;10(12):e0005174. doi: 10.1371/journal.pntd.0005174. eCollection 2016 Dec.

31.

Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection?

Gounder PP, Haering C, Bruden DJT, Townshend-Bulson L, Simons BC, Spradling PR, McMahon BJ.

J Clin Gastroenterol. 2018 Jan;52(1):60-66. doi: 10.1097/MCG.0000000000000753.

PMID:
27875352
32.

Complete Genome Sequence of Leptospira alstonii Serovar Room22 Strain GWTS #1.

Nally JE, Bayles DO, Hurley D, Fanning S, McMahon BJ, Arent Z.

Genome Announc. 2016 Nov 10;4(6). pii: e01230-16. doi: 10.1128/genomeA.01230-16.

33.

Hepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort Analysis.

Gounder PP, Bulkow LR, Snowball M, Negus S, Spradling PR, McMahon BJ.

J Pediatr. 2016 Nov;178:206-213. doi: 10.1016/j.jpeds.2016.08.017. Epub 2016 Aug 30.

34.

Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.

McMahon BJ, Bruden D, Townshend-Bulson L, Simons B, Spradling P, Livingston S, Gove J, Hewitt A, Plotnik J, Homan C, Espera H, Negus S, Snowball M, Barbour Y, Bruce M, Gounder P.

Clin Gastroenterol Hepatol. 2017 Mar;15(3):431-437.e2. doi: 10.1016/j.cgh.2016.10.012. Epub 2016 Oct 17.

35.

Reply.

Brown RS Jr, McMahon BJ, Lok AS, Wong JB, Ahmed AT, Mouchli MA, Wang Z, Prokop LJ, Murad MH, Mohammed K.

Hepatology. 2016 Nov;64(5):1824-1825. doi: 10.1002/hep.28617. Epub 2016 Jun 24. No abstract available.

36.

Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.

Nelson NP, Easterbrook PJ, McMahon BJ.

Clin Liver Dis. 2016 Nov;20(4):607-628. doi: 10.1016/j.cld.2016.06.006. Review. Erratum in: Clin Liver Dis. 2017 May;21(2):xiii.

37.

Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia.

Waisbren J, Dinner S, Altman J, Frankfurt O, Helenowski I, Gao J, McMahon BJ, Stein BL.

Int J Hematol. 2017 Jan;105(1):44-51. doi: 10.1007/s12185-016-2081-4. Epub 2016 Aug 24.

PMID:
27558575
38.

Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors' reply.

Gounder PP, Bulkow LR, McMahon BJ.

Aliment Pharmacol Ther. 2016 Sep;44(6):650-1. doi: 10.1111/apt.13730. No abstract available.

39.

Editorial Commentary: Sliding Down the Cascade of Care for Chronic Hepatitis B Virus Infection.

McMahon BJ.

Clin Infect Dis. 2016 Nov 1;63(9):1209-1211. Epub 2016 Aug 2. No abstract available.

PMID:
27486113
40.

Update on Anticoagulation: What the Interventional Radiologist Needs to Know.

Kamath SD, McMahon BJ.

Semin Intervent Radiol. 2016 Jun;33(2):122-31. doi: 10.1055/s-0036-1582124. Review.

41.

The changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people.

Connelly M, Bruce MG, Bulkow L, Snowball M, McMahon BJ.

Liver Int. 2016 Dec;36(12):1829-1835. doi: 10.1111/liv.13173. Epub 2016 Jun 16.

PMID:
27224493
42.

Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.

Gounder PP, Bulkow LR, Meltzer MI, Bruce MG, Hennessy TW, Snowball M, Spradling PR, Adhikari BB, McMahon BJ.

Int J Circumpolar Health. 2016 May 18;75:31115. doi: 10.3402/ijch.v75.31115. eCollection 2016.

43.

Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.

Gounder PP, Bulkow LR, Snowball M, Negus S, Spradling PR, Simons BC, McMahon BJ.

Aliment Pharmacol Ther. 2016 Jun;43(11):1197-207. doi: 10.1111/apt.13621. Epub 2016 Apr 8.

44.

A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.

Simons BC, Spradling PR, Bruden DJ, Zanis C, Case S, Choromanski TL, Apodaca M, Brogdon HD, Dwyer G, Snowball M, Negus S, Bruce MG, Morishima C, Knall C, McMahon BJ.

J Infect Dis. 2016 Jul 15;214(2):273-80. doi: 10.1093/infdis/jiw142. Epub 2016 Apr 7.

45.

Survey of Provider Transfusion Practices for Oncology Patients in an Academic Medical Center.

Buck RJ, Wachsberg KN, Weaver AC, Hansen LO, McMahon BJ, Dombrowski L, O'Leary KJ.

South Med J. 2016 Apr;109(4):267-71. doi: 10.14423/SMJ.0000000000000444.

PMID:
27043813
46.

Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C.

Livingston SE, Townshend-Bulson LJ, Bruden DJ, Homan CE, Gove JE, Plotnik JN, Simons BC, Spradling PR, McMahon BJ.

Int J Circumpolar Health. 2016 Mar 29;75:30696. doi: 10.3402/ijch.v75.30696. eCollection 2016.

47.

Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people.

Ching LK, Gounder PP, Bulkow L, Spradling PR, Bruce MG, Negus S, Snowball M, McMahon BJ.

Liver Int. 2016 Oct;36(10):1507-15. doi: 10.1111/liv.13129. Epub 2016 Apr 6.

48.

Reply.

Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, Williams J, Livingston SE.

Hepatology. 2016 Aug;64(2):690-1. doi: 10.1002/hep.28501. Epub 2016 Apr 5. No abstract available.

PMID:
26890566
49.

Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.

Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, Toomey M, Townshend-Bulson L, Rudolph K, Bulkow L, Spradling PR, Baum R, Hennessy T, McMahon BJ.

J Infect Dis. 2016 Jul 1;214(1):16-22. doi: 10.1093/infdis/jiv748. Epub 2016 Jan 21.

PMID:
26802139
50.

Persistence of seropositivity among persons vaccinated for hepatitis A during infancy by maternal antibody status: 15-year follow-up.

Spradling PR, Bulkow LR, Negus SE, Homan C, Bruce MG, McMahon BJ.

Hepatology. 2016 Mar;63(3):703-11. doi: 10.1002/hep.28375. Epub 2016 Feb 1.

Supplemental Content

Loading ...
Support Center